VC-backed Rodin Therapeutics adds Singer to board
Cambridge, Massachusetts-based Rodin Therapeutics, a biotech company focused on developing new treatments for neurological disorders, has named Samantha Singer to its board of directors. Singer is the chief operating officer at the Board Institute of MIT and Harvard. Rodin Therapeutics is backed by Atlas Venture.
21 December 2015•3 mins read
